Senti Biosciences Holdings, Inc. (SNTI)
NASDAQ: SNTI · Real-Time Price · USD
1.010
-0.030 (-2.88%)
May 15, 2026, 4:00 PM EDT - Market closed

SNTI Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
0.020.02-2.564.292.76
Revenue Growth (YoY)
----40.25%55.23%387.81%
Gross Profit
0.020.02-2.564.292.76
Selling, General & Admin
25.2826.1626.3737.1838.2321.25
Research & Development
33.5937.5934.3632.1528.1521.96
Other Operating Expenses
11.935.050.3125.96--0.02
Total Operating Expenses
70.868.861.0495.2966.3743.19
Operating Income
-57-68.78-61.04-92.73-62.08-40.45
Interest Income
0.630.930.952.861.70.01
Other Non-Operating Income (Expense)
4.666.417.36.4610.72-14.86
Total Non-Operating Income (Expense)
5.297.348.259.3212.42-14.85
Pretax Income
-51.71-61.44-52.79-83.41-49.67-55.3
Net Income
-51.55-61.44-52.79-71.06-58.21-55.32
Earnings From Discontinued Operations
---12.35-8.55-
Net Income to Common
-51.55-61.44-52.79-71.06-58.21-55.32
Shares Outstanding (Basic)
28225430
Shares Outstanding (Diluted)
28225430
Shares Change (YoY)
364.51%389.20%3.58%69.93%796.58%-79.92%
EPS (Basic)
-1.92-2.73-12.03-18.80-22.30-190.00
EPS (Diluted)
-1.92-2.73-12.03-18.80-22.30-190.00
Shares Outstanding
31.1430.884.834.574.410.65
Free Cash Flow
-36.97-43.64-41.42-64.43-76.27-40.18
Free Cash Flow Per Share
-1.34-1.94-9.01-14.52-29.21-137.96
Gross Margin
100.00%100.00%-100.00%100.00%100.00%
Operating Margin
-259082.00%-312632.00%--3620.73%-1448.53%-1464.90%
Profit Margin
-235032.00%-279264.00%--3256.77%-1158.77%-2002.79%
FCF Margin
-168059.00%-198364.00%--2515.93%-1779.51%-1455.20%
EBITDA
-53.6-65.14-57.2-87.3-58.16-37.44
EBITDA Margin
-243632.00%-296100.00%--3408.75%-1357.07%-1355.89%
EBIT
-57-68.78-61.04-92.73-62.08-40.45
EBIT Margin
-259082.00%-312632.00%--3620.73%-1448.53%-1464.90%
Updated May 14, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q